• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Women's Anxiety Rose in States Affected by Fall of Roe v. Wade

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 25, 2024.

By Dennis Thompson HealthDay Reporter

THURSDAY, Jan. 25, 2024 -- Women are suffering more anxiety and depression in states that banned abortion after the Supreme Court overturned Roe v. Wade, a new study shows.

The court’s Dobbs decision in June 2022 triggered laws banning abortion in 13 states.

In the six months after, symptoms of anxiety and depression increased among women living in those states, particularly those ages 18 to 45, researchers report Jan. 23 in the Journal of the American Medical Association.

“These findings suggest that changes in abortion policy can impact mental health at the population level,” said senior study author Matthew Eisenberg, director of the Johns Hopkins Center for Mental Health and Addiction Policy in Baltimore.

“Policymakers should, of course, be aware of the first-order impacts of policies, but studies such as this suggest that they should also consider downstream policy effects on mental health, even when a policy is not specifically targeting mental health,” Eisenberg added in a Hopkins news release.

For the study, researchers analyzed data drawn from the Household Pulse Survey, an online survey the U.S. Census Bureau conducts every two weeks to track health and socioeconomic conditions in the United States.

The survey includes a four-question screening tool often used in primary care to assess anxiety and depression, researchers said.

The study examined 13 waves of data drawn from the survey, spanning from late December 2021 to January 2023.

Nearly 719,000 people participated in survey during that period, including about 160,000 from trigger states.

Researchers found that anxiety and depression scores were nearly 9% higher in all trigger states than in non-trigger states in the six months following the decision.

In particular, scores increased 3% among women ages 18 to 45 in trigger states, but decreased by 1.8% in non-trigger states, results show.

The trigger states were Arkansas, Idaho, Kentucky, Louisiana, Mississippi, Missouri, North Dakota, Oklahoma, South Dakota, Tennessee, Texas, Utah, and Wyoming.

Researchers next plan to examine other potential impacts of Dobbs -- for example, to determine whether new doctors are avoiding states where abortion is now banned or heavily restricted.

“Prior to Dobbs, research established that denial to abortion access was associated with adverse outcomes, including symptoms of anxiety,” said lead researcher Benjamin Thornburg, a doctoral student at the Johns Hopkins Bloomberg School of Public Health.

“Emerging research has suggested that a similar trend may emerge at the national level as states enact more restrictive abortion policies following Dobbs, which is precisely what our study reveals,” Thornburg added.

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.